Displaying 1 - 20 of 330
Amphastar Pharmaceuticals Inc.
Date Sent
File
Warning Letter to Amphastar Pharmaceuticals Inc.
(173.09 KB)
FTC Renews Challenge of More Than 200 Improper Patent Listings
Date
Continuing its efforts to promote competition and lower drug prices, today the Federal Trade Commission renewed its challenges against dozens of improperly listed device patents that shield brand-name...
Novartis Pharmaceuticals Corp.
Date Sent
File
Warning Letter to Novartis Pharmaceuticals Corp.
(175.19 KB)
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
221 0114
Docket Number
9437
Case Status
Pending
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
P221200
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Date
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty...
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Tuesday, January 14, 2025. The open meeting will commence at 11 a.m. ET...
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
Date
Today, the U.S. Court of Appeals for the Federal Circuit affirmed a lower district court order against pharmaceutical maker Teva requiring the drugmaker to delist several asthma inhaler patents from...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Date
Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group...
FTC Seeks Public Comments on Cooperativa De Farmacias Puertorriqueñas Request to Modify Final Commission Order
Date
The Federal Trade Commission is seeking public comment on a petition by a Puerto Rican cooperative of independent pharmacy owners, Cooperativa De Farmacias Puertorriqueñas, also known as Coopharma...
FTC Submits Comment Supporting Proposed FDA Guidance on Interchangeable Biosimilar Drugs
Date
The Federal Trade Commission submitted a comment supporting the Food and Drug Administration’s (FDA) draft guidance regarding interchangeable biosimilar drugs that can be substituted for brand-name...
Displaying 1 - 20 of 330